InterAx and @Boehringer take first steps towards collaborating to unlock orphan targets leveraging InterAx AI driven discovery platform.
Collaborative efforts aim to accelerate and improve the prediction of first in class small molecule agonists for a challenging orphan GPCR π
@InterAxBiotech is pleased to announce that Carola Weiss has joined the company as VP Business Development. Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical industry.
InterA successfully completed its EU #H2020 project 4 months ahead of schedule. The newly developed discovery platform combines for the first time classical pharmacology, computational methods, systems biology and AI to revolutionise π drug discovery.
https://t.co/jGBwUXNJ42
If you want to learn about analysis of complex GPCR signaling data with #systemsbiology - see the talk of Susanne Roth at GM of the European Research Network on Signal Transduction #ERNEST.
Today at 2-2:30 PM CET
-> Register for free https://t.co/DdVcP0a5Du
#Horizon2020#EU_EIC
Today InterAx is connecting with EIC Beneficiary colleagues, corporatesa and EIC staff memebrs at the #EUeic Innovation Hub Visit
#EICAccelerator#H2020
Ring, ring, ring π Berlin calling!
Today at the #EUeic Innovation Hub Visit, we will discover the #innovation landscape in and around the vibrant German capital β¨
Stay tuned to learn more π
#eicAccelerator
InterAx and Prof. @JanaSelent from the @hospitaldelmar (IMIM) collaborates to identify antiviral drugs COVID-19 treatment by combining virtual screening of a 3D-structural database and assessing the effectiveness of these compounds to block viral entry.
https://t.co/6tRj7SKipe
Happy to be one of the 10 Swiss Biotech Startups to watch in 2020! Thanks @venturelab_ch to always keep a very close eye on the Swiss startup ecosystem, analyse trends and publish your reports.
https://t.co/u5a6qLb3Jp
Absolutely fascinating talk on why AI and science need to now come together. Thanks to Danielle Ralic, CEO & Founder, IntrepidAnalytics.
I have so many questions!
#Pharmacology2019#WomenInScience
InterAx Biotech AG and GPCR Therapeutics Inc. collaborate for the identification of compounds with superior biological properties targeting GPCR heteromers using the InterAx systems biology platform.
https://t.co/ornTMYfcO7
#biotech#platform#systemsbiology#GPCR
.@InterAxBiotech assists biotech and pharma companies in intelligent drug candidate design & selection.
Want to understand how their #systembiology platform works? Visit CEO Martin Ostermaier at the Swiss Pavilion (booth 3741) at the #BIO2019 convention.
#biotech#innosuisse